Immunological HCV-associated thrombocytopenia: Short review

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Dimitroulis, Dimitrios ^a   Valsami, Serena ^b   Stamopoulos, Paraskevas ^a   Kouraklis, Gregory ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CYCLOSPORIN A; ELTROMBOPAG; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; ROMIPLOSTIM;

AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; CLINICAL FEATURE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE COUNT; THROMBOCYTOPENIA; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

HEPACIVIRUS; HEPATITIS C; HUMANS; THROMBOCYTOPENIA;

EID: 84864937779     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/378653     Document Type: Review

References (43)

1. Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES), Consensus conference. Treatment of hepatitis C Gastroentérologie Clinique et Biologique 2002 26 2 B303 B320
2. NIH, NIH consensus statement on management of hepatitis C: 2002 NIH Consens State Sci Statements 2002 19 3 1 46
3. Hassan M. M., Frome A., Patt Y. Z., El-Serag H. B., Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States Journal of Clinical Gastroenterology 2002 35 3 266 269 (Pubitemid 34913096)
4. Davila J. A., Morgan R. O., Shaib Y., McGlynn K. A., El-Serag H. B., Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study Gastroenterology 2004 127 5 1372 1380 (Pubitemid 39457763)
5. Centers for Disease Control and Prevention, Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease MMWR Recommendations and Reports 1998 47 RR-19 1 39
6. El-Serag H. B., Hampel H., Yeh C., Rabeneck L., Extrahepatic manifestations of hepatitis C among United States male veterans Hepatology 2002 36 6 1439 1445 (Pubitemid 35403535)
7. Gumber S. C., Chopra S., Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations Annals of Internal Medicine 1995 123 8 615 620
8. Loustaud-Ratti V., Riche A., Liozon E., Labrousse F., Soria P., Rogez S., Babany G., Delaire L., Denis F., Vidal E., Prevalence and characteristics of Sjgren's syndrome or sicca syndrome in chronic hepatitis C virus infection: a prospective study The Journal of Rheumatology 2001 28 10 2245 2251 (Pubitemid 32947870)
9. Giordano N., Amendola A., Papakostas P., Cipolli F., Agate V. M., Battisti E., Marchi B., Nuti R., Immune and autoimmune disorders in HCV chronic liver disease: personal experience and commentary on literature New Microbiologica 2005 28 4 311 317 (Pubitemid 41823927)
10. Nagamine T., Ohtuka T., Takehara K., Arai T., Takagi H., Mori M., Thrombocytopenia associated with hepatitis C viral infection Journal of Hepatology 1996 24 2 135 140 (Pubitemid 26059114)
11. Liebman H. A., Viral-associated immune thrombocytopenic purpura Hematology 2008 2008 1 212 218
12. Sloand E. M., Klein H. G., Banks S. M., Vareldzis B., Merritt S., Pierce P., Epidemiology of thrombocytopenia in HIV infection European Journal of Haematology 1992 48 3 168 172
13. Sullivan P. S., Hanson D. L., Chu S. Y., Jones J. L., Ciesielski C. A., Surveillance for thrombocytopenia in persons infected with HIV: results from the multistate adult and adolescent spectrum of disease project Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1997 14 4 374 379
14. Mientjes G. H. C., van Ameijden E. J. C., Mulder J. W., van Den Hoek J. A. R., Coutinho R. A., Von Dem Borne A. E., Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual men British Journal of Haematology 1992 82 3 615 619
15. Liebman H. A., Stasi R., Secondary immune thrombocytopenic purpura Current Opinion in Hematology 2007 14 5 557 573 (Pubitemid 47457647)
16. Zhang L., Li H., Zhao H., Ji L., Yang R., Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: experience from a single Chinese center European Journal of Haematology 2003 70 3 196 197 (Pubitemid 36606083)
17. Cacoub P., Renou C., Rosenthal E., Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C Medicine 2000 79 1 47 56 (Pubitemid 30077736)
18. Marroni M., Gresele P., Landonio G., Lazzarin A., Coen M., Vezza R., Silva Sinnone M., Boschetti E., Nosari A. M., Stagni G., Nenci G. G., Pauluzzi S., Interferon- is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial Annals of Internal Medicine 1994 121 6 423 429
19. Pivetti S., Novarino A., Merico F., Bertero M. T., Brunetto M. R., Bonino F., Caligaris-Cappio F., High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders British Journal of Haematology 1996 95 1 204 211 (Pubitemid 26340253)
20. Pawlotsky J. M., Bouvier M., Fromont P., Deforges L., Duval J., Dhumeaux D., Bierling P., Hepatitis C virus infection and autoimmune thrombocytopenic purpura Journal of Hepatology 1995 23 6 635 639 (Pubitemid 26014854)
21. Garca-Surez J., Burgaleta C., Hernanz N., Albarran F., Tobaruela P., Alvarez-Mon M., HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant 2b-interferon therapy British Journal of Haematology 2000 110 1 98 103 (Pubitemid 30627497)
22. Pockros P. J., Duchini A., McMillan R., Nyberg L. M., McHutchison J., Viernes E., Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection The American Journal of Gastroenterology 2002 97 8 2040 2045
23. Dufour J. F., Pradat P., Ruivard M., Hot A., Dumontet C., Broussolle C., Trepo C., Sve P., Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases European Journal of Gastroenterology Hepatology 2009 21 3 245 253
24. Chiao E. Y., Engels E. A., Kramer J. R., Pietz K., Henderson L., Giordano T. P., Landgren O., Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection Archives of Internal Medicine 2009 169 4 357 363
25. Breitenstein S., Dimitroulis D., Petrowsky H., Puhan M. A., Mllhaupt B., Clavien P. A., Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis British Journal of Surgery 2009 96 9 975 981
26. Hamaia S., Li C., Allain J. P., The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines Blood 2001 98 8 2293 2300
27. Rajan S., Liebman H. A., Treatment of hepatitis C related thrombocytopenia with interferon alpha American Journal of Hematology 2001 68 3 202 209 (Pubitemid 32983211)
28. Panzer S., Seel E., Brunner M., Krmczi G. F., Schmid M., Ferenci P., Peck-Radosavljevic M., Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia European Journal of Haematology 2006 77 6 513 517 (Pubitemid 44690797)
29. Rajan S. K., Espina B. M., Liebman H. A., Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura British Journal of Haematology 2005 129 6 818 824 (Pubitemid 40904534)
30. Cines D. B., Blanchette V. S., Immune thrombocytopenic purpura The New England Journal of Medicine 2002 346 13 995 1008
31. Danish F. A., Koul S. S., Subhani F. R., Rabbani A. E., Yasmin S., Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag The Saudi Journal of Gastroenterology 2010 16 1 51 56
32. Sakuraya M., Murakami H., Uchiumi H., Hatsumi N., Akiba T., Yokohama A., Matsushima T., Tsukamoto N., Morita K., Karasawa M., Ogawara H., Nojima Y., Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection European Journal of Haematology 2002 68 1 49 53 (Pubitemid 34407542)
33. Provan D., Stasi R., Newland A. C., Blanchette V. S., Bolton-Maggs P., Bussel J. B., Chong B. H., Cines D. B., Gernsheimer T. B., Godeau B., Grainger J., Greer I., Hunt B. J., Imbach P. A., Lyons G., McMillan R., Rodeghiero F., Sanz M. A., Tarantino M., Watson S., Young J., Kuter D. J., International consensus report on the investigation and management of primary immune thrombocytopenia Blood 2010 115 2 168 186
34. Liebman H. A., Pullarkat V., Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics Hematology 2011 2011 1 384 390
35. Arnold D. M., Dentali F., Crowther M. A., Meyer R. M., Cook R. J., Sigouin C., Fraser G. A., Lim W., Kelton J. G., Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura Annals of Internal Medicine 2007 146 1 25 33 (Pubitemid 351650318)
36. Cacoub P., Delluc A., Saadoun D., Landau D. A., Sene D., Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: where do we stand? Annals of the Rheumatic Diseases 2008 67 3 283 287 (Pubitemid 351281259)
37. Isenberg D. A., B cell targeted therapies in autoimmune diseases The Journal of Rheumatology 2006 77 24 28
38. Berchtold P., McMillan R., Therapy of chronic idiopathic thrombocytopenic purpura in adults Blood 1989 74 7 2309 2317 (Pubitemid 19286446)
39. Iga D., Tomimatsu M., Endo H., Ohkawa S. I., Yamada O., Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon- therapy: possible etiology of HCV-associated immune thrombocytopenia European Journal of Haematology 2005 75 5 417 423 (Pubitemid 41445082)
40. Bussel J. B., Cheng G., Saleh M. N., Psaila B., Kovaleva L., Meddeb B., Kloczko J., Hassani H., Mayer B., Stone N. L., Arning M., Provan D., Jenkins J. M., Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura The New England Journal of Medicine 2007 357 22 2237 2247 (Pubitemid 350190754)
41. Kuter D. J., Bussel J. B., Lyons R. M., Pullarkat V., Gernsheimer T. B., Senecal F. M., Aledort L. M., George J. N., Kessler C. M., Sanz M. A., Liebman H. A., Slovick F. T., de Wolf J. T. M., Bourgeois E., Guthrie T. H., Newland A., Wasser J. S., Hamburg S. I., Grande C., Lefrre F., Lichtin A. E., Tarantino M. D., Terebelo H. R., Viallard J. F., Cuevas F. J., Go R. S., Henry D. H., Redner R. L., Rice L., Schipperus M. R., Guo D. M., Nichol J. L., Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial The Lancet 2008 371 9610 395 403 (Pubitemid 351181334)
42. McHutchison J. G., Dusheiko G., Shiffman M. L., Rodriguez-Torres M., Sigal S., Bourliere M., Berg T., Gordon S. C., Campbell F. M., Theodore D., Blackman N., Jenkins J., Afdhal N. H., Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C The New England Journal of Medicine 2007 357 22 2227 2236 (Pubitemid 350190753)
43. Bussel J. B., Cheng G., Saleh M. N., Incidence of thromboembolic events across eltrombopag clinical trials in chronic immune thrombocytopenia (ITP) Blood 2010 116, article 70